by Co-Lab AccelBio | Mar 29, 2023 | Newsletter
The launch of new drugs in the market has the solid purpose of fulfilling patient needs. Nowadays, the approval of new drug products depends on evidence of efficacy, safety and quality, reflected in regulatory requirements, which are rules of law to protect...
by Co-Lab AccelBio | Mar 1, 2023 | Associates, Events, Prizes
Our Mariana Branco just won the third prize of the AIDFM-CETERA Award for her article “Human multilineage pro-epicardium/foregut organoids support the development of an epicardium/myocardium organoidum” published in Nature Communications. In this work,...
by Co-Lab AccelBio | Mar 1, 2023 | Mission, Training
Last week Pedro Silva, President of the Direction, and Bárbara Gomes, AccelBio’s CEO, were in Tel Aviv to get to know the Israeli innovation ecosystem. With meetings with Tel Aviv University (Blavatnik Center for Drug Discovery) and Weizmann Institute of Science...
by Co-Lab AccelBio | Feb 28, 2023 | Associates, Interviews
In an interview with Nuno de Noronha, Sapo Lifestyle, Bárbara Gomes and Hugo Almeida explained how AccelBio can contribute to the Portuguese biomedical ecosystem. Please check the interview here:...
by Co-Lab AccelBio | Jan 4, 2023 | Uncategorized
The 3rd CoLABs Annual Meeting was held in Faro, Algarve, and organized by Agência Nacional de Inovação. During two days we had the pleasure to share AccelBio’s activities with other CoLABs, discuss opportunities and, above all, strength this amazing network of...
